CLINICAL TRIALS PROFILE FOR DOXEPIN HYDROCHLORIDE
✉ Email this page to a colleague
505(b)(2) Clinical Trials for Doxepin Hydrochloride
| Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|---|
| OTC | NCT02229539 ↗ | Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy | Completed | National Cancer Institute (NCI) | Phase 3 | 2014-11-01 | The purpose of this study is to test whether a mouthwash made with a drug called doxepin can reduce the pain caused by mouth sores resulting from radiation therapy. A number of mouth rinse preparations exist for patients with treatment-related oral mucositis pain such as the DLA rinse, an over-the-counter medication. This study will evaluate the effects of doxepin compared to DLA (diphenhydramine, lidocaine and antacids) and placebo.Doxepin is approved by the Food and Drug Administration (FDA) for the treatment of depression, anxiety, long-term pain management, as well as management of rash. |
| OTC | NCT02229539 ↗ | Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy | Completed | Alliance for Clinical Trials in Oncology | Phase 3 | 2014-11-01 | The purpose of this study is to test whether a mouthwash made with a drug called doxepin can reduce the pain caused by mouth sores resulting from radiation therapy. A number of mouth rinse preparations exist for patients with treatment-related oral mucositis pain such as the DLA rinse, an over-the-counter medication. This study will evaluate the effects of doxepin compared to DLA (diphenhydramine, lidocaine and antacids) and placebo.Doxepin is approved by the Food and Drug Administration (FDA) for the treatment of depression, anxiety, long-term pain management, as well as management of rash. |
| >Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for Doxepin Hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00280839 ↗ | Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation | Completed | Ortho-McNeil Neurologics, Inc. | Phase 3 | 1969-12-31 | The purpose of this research study is to determine if topiramate is safe and effective in the treatment of smoking cessation |
| NCT00280839 ↗ | Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation | Completed | University of Cincinnati | Phase 3 | 1969-12-31 | The purpose of this research study is to determine if topiramate is safe and effective in the treatment of smoking cessation |
| NCT00280839 ↗ | Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation | Completed | Lindner Center of HOPE | Phase 3 | 1969-12-31 | The purpose of this research study is to determine if topiramate is safe and effective in the treatment of smoking cessation |
| NCT00465972 ↗ | The Treatment of Insomnia in Patients With HIV Disease | Completed | Duke University | Phase 4 | 2007-03-01 | This study is designed to evaluate the efficacy of two commonly prescribed sleep aids for use in patients who are HIV positive and suffer from insomnia. |
| NCT00755495 ↗ | Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia | Completed | Takeda | Phase 2 | 2006-07-01 | The purpose of this study is to determine the efficacy of ramelteon, once daily (QD), combined with doxepin in treating subjects with insomnia. |
| NCT01156142 ↗ | Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy | Completed | National Cancer Institute (NCI) | Phase 3 | 2010-12-01 | RATIONALE: Doxepin hydrochloride may be an effective treatment for oral mucositis pain in patients undergoing radiation therapy with or without chemotherapy. PURPOSE: This randomized phase III trial is studying doxepin hydrochloride to see how well it works compared to placebo in treating oral mucositis pain in patients with head and neck cancer undergoing radiation therapy with or without chemotherapy. |
| NCT01156142 ↗ | Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy | Completed | Alliance for Clinical Trials in Oncology | Phase 3 | 2010-12-01 | RATIONALE: Doxepin hydrochloride may be an effective treatment for oral mucositis pain in patients undergoing radiation therapy with or without chemotherapy. PURPOSE: This randomized phase III trial is studying doxepin hydrochloride to see how well it works compared to placebo in treating oral mucositis pain in patients with head and neck cancer undergoing radiation therapy with or without chemotherapy. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Doxepin Hydrochloride
Condition Name
Clinical Trial Locations for Doxepin Hydrochloride
Trials by Country
Clinical Trial Progress for Doxepin Hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for Doxepin Hydrochloride
Sponsor Name
